We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$10.7B
AUM Growth
-$1.2B
Cap. Flow
-$1.77B
Cap. Flow %
-16.59%
Top 10 Hldgs %
17.61%
Holding
1,734
New
553
Increased
270
Reduced
235
Closed
408

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$107M
2
STX icon
Seagate
STX
+$46.6M
3
ROP icon
Roper Technologies
ROP
+$46.2M
4
INTC icon
Intel
INTC
+$44.7M
5
NTNX icon
Nutanix
NTNX
+$42.7M

Sector Composition

Rank Sector Weight
1 Technology 10.53%
2 Financials 5.9%
3 Healthcare 3.32%
4 Energy 2.62%
5 Communication Services 2.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GGROW
1076
Gogoro Inc Warrant
GGROW
$205K
$124K ﹤0.01%
4,834,590
HPE icon
1077
Hewlett Packard
HPE
$63.8B
$124K ﹤0.01%
+8,024
New +$160K
SLRN
1078
DELISTED
ACELYRIN
SLRN
$124K ﹤0.01%
+50,000
New +$119K
RBOT.WS
1079
DELISTED
Vicarious Surgical Inc Warrants
RBOT.WS
$123K ﹤0.01%
3,913,105
MPAA icon
1080
Motorcar Parts of America
MPAA
$264M
$120K ﹤0.01%
+12,618
New +$110K
LOGC
1081
DELISTED
ContextLogic
LOGC
$119K ﹤0.01%
+17,064
New +$127K
FUFUW icon
1082
BitFuFu Inc Warrant
FUFUW
$897K
$118K ﹤0.01%
+267,051
New +$122K
BZAIW
1083
Blaize Holdings Warrants
BZAIW
$6.89M
$117K ﹤0.01%
+615,000
New +$265K
BEAGR
1084
Bold Eagle Acquisition Corp Right
BEAGR
$115K ﹤0.01%
+500,000
New +$126K
CMPX icon
1085
PUT
Compass Therapeutics
CMPX
$375M
$114K ﹤0.01%
+60,000
New +$160K
GPATW
1086
GP-Act III Acquisition Corp Warrants
GPATW
$114K ﹤0.01%
612,500
HLLY.WS
1087
DELISTED
Holley Inc Warrants
HLLY.WS
$112K ﹤0.01%
2,242,360
JACS.RT
1088
Jackson Acquisition Co II Rights
JACS.RT
$111K ﹤0.01%
+443,751
New +$101K
DMYY.WS
1089
DELISTED
dMY Squared Technology Group Warrants
DMYY.WS
$110K ﹤0.01%
+115,839
New +$50.7K
FTW.WS
1090
Presidio Production Co Warrants
FTW.WS
$110K ﹤0.01%
333,332
BRBS icon
1091
Blue Ridge Bankshares
BRBS
$314M
$107K ﹤0.01%
+32,838
New +$112K
LPBBW
1092
Launch Two Acquisition Corp Warrant
LPBBW
$105K ﹤0.01%
+500,000
New +$105K
HAL icon
1093
PUT
Halliburton
HAL
$26.8B
$101K ﹤0.01%
4,000
MACIW
1094
Melar Acquisition Corp I Warrant
MACIW
$1.04M
$100K ﹤0.01%
742,500
RVMDW icon
1095
Revolution Medicines Inc Warrant
RVMDW
$105M
$99.1K ﹤0.01%
2,606,720
+11,475
+0.4% +$1.42K
FTK icon
1096
Flotek Industries
FTK
$881M
$98.8K ﹤0.01%
+11,863
New +$102K
KKR.PRD
1097
KKR & Co 6.25% Series D Preferred Stock
KKR.PRD
$2.25B
0
SLDPW icon
1098
Solid Power Inc Warrant
SLDPW
$9.12M
$95.2K ﹤0.01%
560,466
-87,880
-14% -$20.2K
CRVS icon
1099
Corvus Pharmaceuticals
CRVS
$1.09B
$94.9K ﹤0.01%
+29,858
New +$141K
PRU icon
1100
Prudential Financial
PRU
$42.3B
$94.5K ﹤0.01%
846
+418
+98% +$47.6K

Similar funds

LMR Partners's Q1 2025 Portfolio in Review

As of Q1 2025, LMR Partners held 1,734 positions worth $10.7B, down 10% from $11.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

LMR Partners withdrew a net $1.77B in Q1 2025, closing 408 positions and reducing 235 holdings. Its most notable exit was Endeavor Group Holdings, Inc., an estimated $204M position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, LMR Partners opened a new position in Roper Technologies worth $48.6M.

  • LMR Partners's largest Q1 2025 buy was Roper Technologies: 82,349 shares worth $48.6M.
  • LMR Partners added most to Intra-Cellular Therapies Inc. in Q1 2025, an estimated $107M increase.
  • LMR Partners's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $469M.
  • LMR Partners fully exited Endeavor Group Holdings, Inc. in Q1 2025, selling an estimated $204M.
  • LMR Partners's ten largest holdings make up 18% of its $10.7B portfolio in Q1 2025.
  • LMR Partners opened 553 new positions and closed 408 in Q1 2025.
  • LMR Partners's portfolio value fell 10% quarter-over-quarter to $10.7B.

Based on LMR Partners's 13F filing for Q1 2025, filed 15 May 2025.